Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Vague

Showing results (211-220 of 239) with videos related to

Pageof 24
Sort By:
Diabetes, Obesity & Metabolism|January 12, 2005
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulinI De Leeuw, P Vague, J-L Selam, et al.
Diabete & Metabolisme|January 1, 1989
Stress antecedents and immune status in recently diagnosed type I (insulindependent) diabetes mellitusB Vialettes, J P Ozanon, S Kaplansky, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
The Journal of Nutrition|January 23, 1999
Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in ratsA Gerbi, J M Maixent, J L Ansaldi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 24, 2006
Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemiaS Sejil, B Janand-Delenne, J-F Avierinos, et al.
Thrombosis Research|April 1, 1985
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitroI Juhan-Vague, M Chignard, C Poisson, et al.
Thrombosis and Haemostasis|January 23, 1992
Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levelsI Juhan-Vague, M C Alessi, D Raccah, et al.
Thrombosis and Haemostasis|August 30, 1985
Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisolM F Aillaud, I Juhan-Vague, M C Alessi, et al.
Presse Medicale (Paris, France : 1983)|September 23, 1995
[Bradycardia during treatments of weight loss]D Raccah, P Disdier, D Roybet, et al.
Pageof 24

Showing results (211-220 of 239) with videos related to

Sort By:
Pageof 24
Diabetes, Obesity & Metabolism|January 12, 2005
Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulinI De Leeuw, P Vague, J-L Selam, et al.
Diabete & Metabolisme|January 1, 1989
Stress antecedents and immune status in recently diagnosed type I (insulindependent) diabetes mellitusB Vialettes, J P Ozanon, S Kaplansky, et al.
Arteriosclerosis (Dallas, Tex.)|May 1, 1989
Plasma plasminogen activator inhibitor-1 in angina pectoris. Influence of plasma insulin and acute-phase responseI Juhan-Vague, M C Alessi, P Joly, et al.
Autoimmunity|January 1, 1991
The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type I diabetes mellitusB Vialettes, N Schmitt, M Hirn, et al.
The Journal of Nutrition|January 23, 1999
Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in ratsA Gerbi, J M Maixent, J L Ansaldi, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 24, 2006
Six-year follow-up of a cohort of 203 patients with diabetes after screening for silent myocardial ischaemiaS Sejil, B Janand-Delenne, J-F Avierinos, et al.
Thrombosis Research|April 1, 1985
Possible participation of adenosine 5'-diphosphate, arachidonic acid and paf-acether in the platelet pro-aggregating effect of uncontrolled insulin-dependent diabetic erythrocytes in vitroI Juhan-Vague, M Chignard, C Poisson, et al.
Thrombosis and Haemostasis|January 23, 1992
Daytime fluctuations of plasminogen activator inhibitor 1 (PAI-1) in populations with high PAI-1 levelsI Juhan-Vague, M C Alessi, D Raccah, et al.
Thrombosis and Haemostasis|August 30, 1985
Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisolM F Aillaud, I Juhan-Vague, M C Alessi, et al.
Presse Medicale (Paris, France : 1983)|September 23, 1995
[Bradycardia during treatments of weight loss]D Raccah, P Disdier, D Roybet, et al.
Pageof 24